Tragopogonsaponin L



Compound IDCDAMM00738
Common nameTragopogonsaponin L
IUPAC name[5-hydroxy-3-[3-(4-hydroxyphenyl)propanoyloxy]-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl] 5,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
Molecular formulaC50H74O15

Experimental data

Retention time15.07
Adduct[M+Na]+
Actual mz937.494
Theoretical mz937.492
Error1.69
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7184

Identifiers and class information

Inchi keyCCLLWPLSBGBSKT-UHFFFAOYNA-N
SmilesO=C(OC1C(OC(=O)C23CCC(C)(C)CC3C4=CCC5C6(C)CCC(O)C(C)(C)C6CCC5(C)C4(C)CC2O)OCC(O)C1OC7OC(CO)C(O)C(O)C7O)CCC8=CC=C(O)C=C8
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)12
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)915.126
Computed dipole moment(dipole)4.675
Total solvent accessible surface area (SASA)1100.05
Hydrophobic component of SASA (FOSA)674.801
Hydrophilic component of SASA (FISA)294.418
Pie component of the SASA (PISA)130.835
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2434.06
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)20.75
Free energy of solvation of dipole (dip^2/V)0.0089778
Index of cohesive interaction in solids (ACxDN^.5/SA)0.049906
Globularity descriptor (glob)0.795497
Predicted polarizability in cubic angstroms (QPpolrz)81.591
Predicted hexadecane/gas partition coefficient (QPlogPC16)24.49
Predicted octanol/gas partition coefficient (QPlogPoct)49.952
Predicted water/gas partition coefficient (QPlogPw)32.2
Predicted octanol/water partition coefficient (QPlogPo/w)3.3
Predicted aqueous solubility (QPlogS)-5.608
Conformation-independent predicted aqueous solubility (CIQPlogS)-9.366
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.465
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)15.993
Predicted brain/blood partition coefficient (QPlogBB)-3.563
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5.663
Predicted skin permeability, log Kp (QPlogKp)-4.853
PM3 calculated ionization potential (IP(ev))9.271
PM3 calculated electron affinity (EA(eV))-0.031
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)0.283
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)28.939
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)236.33
Number of nitrogen and oxygen atoms (#NandO)15
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
P60568IL2Interleukin-2T61698SEA
P14679TYRTyrosinaseT97035SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR

Copyright © 2025